Jean-Paul Kress und Ceo - Info zur Person

(1 - 11 von 13

)

MorphoSys ernennt Dr. Jean-Paul Kress zum neuen Chief Executive...

www.goingpublic.de

MorphoSys AG: Nachfolge von Unternehmensgründer Dr. Simon Moroney / Neuer CEO Dr. Jean-Paul Kress tritt Amt am 1. September an

MorphoSys Appoints Jean-Paul Kress As CEO

www.rttnews.com

MorphoSys AG (MOR) said that its Supervisory Board has appointed Jean-Paul Kress as its new Chief Executive Officer, effect on September 1, ...

MorphoSys Appoints Jean-Paul Kress As CEO :: Grabien News

news.grabien.com

(RTTNews) - MorphoSys AG (MOR) said that its Supervisory Board has appointed Jean-Paul Kress as its new Chief Executive Officer, effect on ...

MorphoSys Appoints Jean-Paul Kress as New CEO

www.bionity.com

MorphoSys AG announced that its Supervisory Board has appointed Jean-Paul Kress, M.D., as its new Chief Executive Officer (CEO).

Jean-Paul Kress | LinkedInwww.linkedin.com › today › author › jean-paul-kress

www.linkedin.com

Jean-Paul Kress. CEO at MorphoSys. View articles by Jean-Paul Kress. How a consistent approach to energy management enables success in rapidly changing ...

New CEO at Morphosys - European Biotechnology

european-biotechnology.com

Germany-based MorphoSys AG announced that its Supervisory Board has today appointed Jean-Paul Kress, M.D., as its new Chief Executive Officer. The appointment...

Biogen vet Jean-Paul Kress takes the reins at NYC’s Syntimmune –...

endpts.com

New York City startup Syntimmune has recruited Biogen's former head of global operations Jean-Paul Kress, to lead the company as president and CEO.

Xconomy: Biogen’s Jean-Paul Kress Joins Syntimmune as President and...

xconomy.com

Jean-Paul Kress has been appointed president and CEO of Syntimmune. Kress will also serve as a director of the New York-based drug developer. He replaces